From: The potential role of miR-27a and miR-320a in metabolic syndrome in obese Egyptian females
Parameters | Groups | p-value | |
---|---|---|---|
Group 1 (control n = 23) | Group 2 (metabolic syndrome n = 50) | ||
Body mass index (BMI), kg/m2 | 23.6073 ± 2.874 | 33.59 ± 6.7092*** | P = 0.0001 |
Waist circumference (cm) | 79.3043 ± 5.506 | 112.08 ± 11.11** | P = 0.0041 |
Fasting blood glucose, mg/dl | 80.21 ± 12.44 | 193.6 ± 50.2*** | P = 0.0001 |
Serum insulin, μ IU/ml | 11.8457 ± 3 | 16.652 ± 3.9* | P = 0.013 |
Insulin resistance, HOMA-IR | 2.3207 ± 0.9 | 8.25 ± 2*** | P = 0.0001 |
Total cholesterol, mg/dl | 159.4783 ± 26.1688 | 197 ± 44.49811*** | P = 0.0001 |
Triglycerides, mg/dl | 60.3043 ± 22.85216 | 177.32 ± 30.21*** | P = 0.0001 |
LDL-cholesterol, mg/dl | 79.5217 ± 25.41385 | 122.436 ± 22.12279*** | P = 0.0001 |
VLDL-cholesterol, mg/dl | 12.0609 ± 4.57043 | 35.464 ± 13.78567*** | P = 0.0001 |
HDL-cholesterol, mg/dl | 79.5217 ± 18.76377 | 41.48 ± 9.37633*** | P = 0.0001 |